Thyrocare Technologies Limited — Board Meeting, 23-04-2025: Outcome of Board Meeting

The Board of Directors of Thyrocare Technologies Limited has approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2025. The company reported a standalone profit of ₹21.95 crore for the quarter, up from ₹19.10 crore in the previous year. A final dividend of ₹21 per equity share has been proposed, subject to shareholder approval. The board also appointed M/s. Mehta & Mehta as Secretarial Auditors for five years and reappointed Mr. S. Thangavelu as Cost Auditor for the financial year 2025-26.